Research Progress of Ketogenic Diet (KD) in Clinical Nutritional Adjuvant Therapy

PEI Chenlin; LU Dingqiang; PANG Guangchang

doi:10.13386/j.issn1002-0306.2021080071

Volume 43 Issue 16

Aug. 2022

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2022 > 43(16): 467-475. > DOI: 10.13386/j.issn1002-0306.2021080071

PEI Chenlin, LU Dingqiang, PANG Guangchang. Research Progress of Ketogenic Diet (KD) in Clinical Nutritional Adjuvant Therapy[J]. Science and Technology of Food Industry, 2022, 43(16): 467−475. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021080071.

Citation:

PDF (2213 KB)

Research Progress of Ketogenic Diet (KD) in Clinical Nutritional Adjuvant Therapy

PEI Chenlin^1,,
LU Dingqiang^{1, 2, ,},
PANG Guangchang^{1, 2, ,}

1.
School of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China
2.
Tianjin Key Laboratory of Food Biotechnology, School of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China

More Information

Received Date: August 05, 2021
Available Online: June 07, 2022

Graphical Abstract

Abstract

Abstract

With the development of society and the increasing incidence of many chronic metabolic diseases, ketogenic diet(KD) has been paid more and more attention as a potential, clinical and nutritional adjuvant therapy. At present, there are an increasing number of clinical applications of ketogenic diet as an adjuvant intervention therapy which has a regulating effect on glucose metabolism and has achieved positive results. In this paper, the physiology of ketosis, the basis and safety of ketogenic diet are summarized. From the perspective of metabolism, the advances of the clinical application research of ketogenic diet in the prevention and adjuvant treatment of intractable epilepsy and several representative chronic metabolic diseases such as obesity, diabetes and cancer are introduced, which provides reference ideas for the development of clinical nutrition assisted medical treatment in China.
- ketogenic diet(KD),
- clinical adjuvant therapy,
- intractable epilepsy,
- obesity,
- diabetes,
- cancer

FullText(HTML)

References (108)

References

[1]	陈瑶. 现代文明病与运动健康[J]. 当代体育科技,2018,8(1):218−220,222. [CHEN Y. Modern civilization disease and sports health[J]. Contemporary Sports Technology,2018,8(1):218−220,222. CHEN Y. Modern civilization disease and sports health[J]. Contemporary Sports Technology, 2018, 8(1): 218-220, 222.
[2]	陈宗. 从《黄帝内经》学古人养生[J]. 家庭医药. 就医选药,2021(4):78−79. [CHEN Z. Learn from the ancients’ way of keeping good health from “The Yellow Emperor’s Internal Classic”[J]. Family Medicine. Seek Medical Treatment,2021(4):78−79. CHEN Z. Learn from the ancients' way of keeping good health from "The Yellow Emperor's Internal Classic" [J]. Family Medicine. Seek medical treatment, 2021(4): 78-79.
[3]	CLAUDIA D R, GRETA L, SALIMA F T, et al. Very low calorie ketogenic diets in overweight and obesity treatment: Effects on anthropometric parameters, body composition, satiety, lipid profile and microbiota[J]. Obesity Research & Clinical Practice,2020,14:491−503.
[4]	GEORGE F C. Fuel metabolism in starvation[J]. Annual Review of Nutrition,2006,26:1−22. doi: 10.1146/annurev.nutr.26.061505.111258
[5]	KREBS H A. The regulation of the release of ketone bodies by the liver[J]. Advances in Enzyme Regulation,1966,4:339−354. doi: 10.1016/0065-2571(66)90027-6
[6]	PATRYCJA P, PETER A C. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics[J]. Cell Metabolism,2017,25(2):262−284. doi: 10.1016/j.cmet.2016.12.022
[7]	DANIELA D W, SEPIDEH A G, JULIA T, et al. Ketogenic diet in the treatment of cancer—Where do we stand?[J]. Molecular Metabolism,2020,33:102−121. doi: 10.1016/j.molmet.2019.06.026
[8]	CAHILL G F. Ketosis[J]. Kidney International,1981,20(3):416−25. doi: 10.1038/ki.1981.155
[9]	JAMES W W. History of the ketogenic diet[J]. Epilepsia,2008,49:3−5.
[10]	GUELPA G, MARIE A. La lute contre l’e’pilepse par la de’ sintoxication et par la re’e’ducation alimentaire[J]. Rev Ther Med Chir,1911,78:8−13.
[11]	GEYELIN H R. Fasting as a method for treating epilepsy[J]. Med Rec,1921,999:1037−1039.
[12]	WOODYATT R T. Objects and method of diet adjustment in diabetes[J]. Archives of Internal Medicine,1921,28(2):125−141. doi: 10.1001/archinte.1921.00100140002001
[13]	D'ANDREA M I, ROMAO T T, PIRESDPH J, et al. Ketogenic diet and epilepsy: What we know so far[J]. Frontiers in Neuroscience,2019,13:5. doi: 10.3389/fnins.2019.00005
[14]	PETERMAN M G. Convulsions in childhood; twenty year study of 2500 cases[J]. American Journal of Diseases of Children (1911),1946,72(4):399−410. doi: 10.1001/archpedi.1946.02020330031005
[15]	GIBSON A A, SEIMON R V, LEE C M Y, et al. Do ketogenic diets really suppress appetite? A systematic review and meta‐analysis[J]. Obesity Reviews,2015,16(1):64−76. doi: 10.1111/obr.12230
[16]	LIU Hongyan, YANG Yi, WANG Yunbing, et al. Ketogenic diet for treatment of intractable epilepsy in adults: A meta-analysis of observational studies[J]. Epilepsia Open,2018,3(1):9−17. doi: 10.1002/epi4.12098
[17]	PAOLI A, RUBINI A, VOLEK JS, et al. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets[J]. European Journal of Clinical Nutrition, 2013, 67(Suppl 1) : 789-796.
[18]	GODAY A, BELLIDO D, SAJOUX I, et al. Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus[J]. Nutrition & Diabetes,2016,6(9):e230.
[19]	WHO. Guideline: Sugars intake for adults and children. Guideline 2015, accessedonhttps://www.who.int/publications/i/item/9789241549028.
[20]	LUDWING D S, HU F B, TAPPY L, et al. Dietary carbohydrates: role of quality and quantity in chronic disease[J]. BMJ (Clinical research ed.),2018,361:k2340.
[21]	MAHSHID D, ANDREW M, ZHANG X H, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): A prospective cohort study[J]. The Lancet,2017,390(10107):2050−2062. doi: 10.1016/S0140-6736(17)32252-3
[22]	CAPRIO M, INFANTE M, MORICONI E, et al. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)[J]. Journal of Endocrinological Investigation,2019,42(11):1365−1386. doi: 10.1007/s40618-019-01061-2
[23]	AFSHIN A, FOROUZANFAR M H, REITSMA M B, et al. Health Effects of overweight and obesity in 195 countries over 25 years[J]. The New England Journal of Medicine,2017,377(1):13−27. doi: 10.1056/NEJMoa1614362
[24]	LONGO M, ZATTERALE F, NADERI J, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications[J]. International Journal of Molecular Sciences,2019,20(9):2358. doi: 10.3390/ijms20092358
[25]	MAHLANGU T, DLUDLA P V, NYAMBUYA T M, et al. A systematic review on the functional role of Th1/Th2 cytokines in type 2 diabetes and related metabolic complications[J]. Cytokine,2020,126:154892. doi: 10.1016/j.cyto.2019.154892
[26]	ERIC C W, WILLIAM S Y. Using a low-carbohydrate diet to treat obesity and type 2 diabetes mellitus[J]. Current Opinion in Endocrinology & Diabetes and Obesity,2020,27(5):255−260.
[27]	SCHOLL B S, H¨OLLER A, PICHLER K, Ketogenic diets in patients with inherited metabolic disorders[J]. Journal of Inherited Metabolic Disease, 2015, 38(4) : 765−773.
[28]	KUMAR S, BEHL T, SACHDEVA M, et al. Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus[J]. Life Sciences,2021,264:118661−118661. doi: 10.1016/j.lfs.2020.118661
[29]	DASHTI H M, MATHEW T C, HUSSEIN T, et al. Long-term effects of a ketogenic diet in obese patients[J]. Experimental and Clinical Cardiology,2004,9(3):200−205.
[30]	VANITALLIE T B, NUFERT T H, NUFERT B A. Ketones: Metabolism's ugly duckling[J]. Nutrition Reviews,2003,61(10):327−341. doi: 10.1301/nr.2003.oct.327-341
[31]	IRENE A M, Manohar L. Garg. Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults[J]. Obesity Research & Clinical Practice,2013,7(3):e173−e181. doi: 10.1016/j.orcp.2011.11.001
[32]	CHOI Y J, JEON S-M, SHIN S. Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without type 2 diabetes: A meta-analysis of randomized controlled trials[J]. Nutrients,2020,12(7):2005. doi: 10.3390/nu12072005
[33]	PAOLI A, MANCIN L, BIANCO A, et al. Ketogenic diet and microbiota: Friends or enemies[J]. Genes,2019,10(7):534. doi: 10.3390/genes10070534
[34]	BREHM B J, SEELEY R J, DANIELS S R, et al. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women[J]. The Journal of Clinical Endocrinology & Metabolism,2003,88(4):1617−1623.
[35]	YANCY JR W S, OLSEN M K, GUYTON J R, et al. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia[J]. ACC Current Journal Review,2004,13(8):18−19.
[36]	MUSCOGIURI G, BARREA L, LAUDISIO D, et al. The management of very low-calorie ketogenic diet in obesity outpatient clinic: A practical guide[J]. Journal of Translational Medicine, 2019, 17(Suppl 2) : 7−9.
[37]	SPERA G, MARIANI S. Diete chetogeniche: Ruolo nel trattamento di sovrappeso e obesità[J]. L'Endocrinologo,2017,18(6):285−290. doi: 10.1007/s40619-017-0376-1
[38]	GOMEZ A D, CRUJEIRAS A B, CASTRO A I, et al. Acid–base safety during the course of a very low-calorie-ketogenic diet[J]. Endocrine,2017,58:81−90. doi: 10.1007/s12020-017-1405-3
[39]	MORENO B, BELLIDO D, SAJOUX I, et al. Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity[J]. Endocrine,2014,47(3):793−805. doi: 10.1007/s12020-014-0192-3
[40]	MORENO B, CRUJEIRAS A B, BELLIDO D, et al. Obesity treatment by very low-calorie-ketogenic diet at two years: Reduction in visceral fat and on the burden of disease[J]. Endocrine,2016,54(3):681−690. doi: 10.1007/s12020-016-1050-2
[41]	CRUJEIRAS A B, IZQUIERDO A G, PRIMO D, et al. Epigenetic landscape in blood leukocytes following ketosis and weight loss induced by a very low calorie ketogenic diet (VLCKD) in patients with obesity[J]. Clinical nutrition (Edinburgh, Scotland),2021,40(6):3959−3972. doi: 10.1016/j.clnu.2021.05.010
[42]	SAJOUX I, LORENZO P M, GOMEZ-ARBELAEZ D, et al. Effect of a very-low-calorie ketogenic diet on circulating myokine levels compared with the effect of bariatric surgery or a low-calorie diet in patients with obesity[J]. Nutrients,2019,11(10):2368. doi: 10.3390/nu11102368
[43]	IACOVIDES S, MEIRING R M. The effect of a ketogenic diet versus a high-carbohydrate, low-fat diet on sleep, cognition, thyroid function, and cardiovascular health independent of weight loss: Study protocol for a randomized controlled trial[J]. Trials,2018,19(1):62. doi: 10.1186/s13063-018-2462-5
[44]	KENIG S, PETELIN A, POKLAR VATOVEC T, et al. Assessment of micronutrients in a 12-wk ketogenic diet in obese adults[J]. Nutrition,2019:67−68.
[45]	SCHIAVO L, PILONE V, ROSSETTI G, et al. A 4-week preoperative ketogenic micronutrient-enriched diet is effective in reducing body weight, left hepatic lobe volume, and micronutrient deficiencies in patients undergoing bariatric surgery: A prospective pilot study[J]. Obesity Surgery,2018,28(8):2215−2224. doi: 10.1007/s11695-018-3145-8
[46]	杨辉, 朱江丽, 陈秋霞, 等. 生酮饮食对肥胖影响的研究[J]. 肿瘤代谢与营养电子杂志,2017,4(3):333−337. [YANG H, ZHU L J, CHEN Q X, et al. Study on the effect of ketogenic diet on obesity[J]. Electronic Jourmal of Metabolism and Nutrition of Cancer,2017,4(3):333−337. YANG H, ZHU L J, CHEN Q X, et al. Study on the effect of ketogenic diet on obesity[J]. Electronic Jourmal of Metabolism and Nutrition of Cancer, 2017, 4(3): 333-337.
[47]	刘莎, 徐爱霞, 刘婷, 等. 暴发1型糖尿病的临床特征[J]. 中南大学学报(医学版),2020,45(12):1437−1443. [LIU S, XU A X, LIU T, et al. Clinical characteristics of fulminant type 1 diabetes mellitus[J]. Journal of Central South University (Medical Science),2020,45(12):1437−1443. LIU S, XU A X, LIU T, et al. Clinical characteristics of fulminant type 1 diabetes mellitus[J]. Journal of Central South University (Medical Science), 2020, 45(12): 1437-1443.
[48]	GOSMANOV A R, GOSMANOVA E O, DILLARD-CANNON E, et al. Management of adult diabetic ketoacidosis[J]. Diabetes, Metabolic Syndrome and Obesity:Targets and Therapy,2014,2014(default):255−264. doi: 10.2147/DMSO.S50516
[49]	BHUPATHIRAJU S N, HU F B. Epidemiology of obesity and diabetes and their cardiovascular complications[J]. Circulation research,2016,118(11):1723−1735. doi: 10.1161/CIRCRESAHA.115.306825
[50]	OLAOGUN I, FARAG M, HAMID P. The pathophysiology of type 2 diabetes mellitus in non-obese individuals: An overview of the current understanding[J]. Cureus,2020,12(4):e7614.
[51]	HAN S J, BOYKO E J. The evidence for an obesity paradox in type 2 diabetes mellitus[J]. Diabetes & Metabolism Journal,2018,42(3):179−187.
[52]	GRAVINA G, FERRARI F, NEBBIAI G. The obesity paradox and diabetes[J]. Eating and Weight Disorders: EWD,2020,26:1057−1068.
[53]	DAMBHA-MILLER H, FELDMAN A L, KINMONTH A L, et al. Association between primary care practitioner empathy and risk of cardiovascular events and all-cause mortality among patients with type 2 diabetes: A population-based prospective cohort study[J]. Annals of Family Medicine,2019,17(4):311−318. doi: 10.1370/afm.2421
[54]	DAVIES MJ, D'ALESSIO D A, FRADKIN J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ada) and the European association for the study of diabetes (EASD)[J]. Diabetologia,2018,41(12):2669−2701.
[55]	ALZAHEB RA, ALTEMANI AH. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia[J]. Diabetes, Metabolic Syndrome and Obesity:Targets and Therapy,2018,11:15−21. doi: 10.2147/DMSO.S156214
[56]	BUSE J B, WEXLER D J, TSAPAS A, et al. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)[J]. Diabetologia,2020,63(2):221−228. doi: 10.1007/s00125-019-05039-w
[57]	AHMED S R, BELLAMKONDA S, ZILBERMINT M, et al. Effects of the low carbohydrate, high fat diet on glycemic control and body weight in patients with type 2 diabetes: experience from a community-based cohort[J]. BMJ Open Diabetes Research & Care,2020,8(1):e000980.
[58]	UNWIN D, UNWIN J. Low carbohydrate diet to achieve weight loss and improve HbA_1c in type 2 diabetes and pre-diabetes: Experience from one general practice[J]. Practical Diabetes,2014,31(2):76−79. doi: 10.1002/pdi.1835
[59]	SACKS F M, CAREY V J, ANDERSON C A M, et al. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity[J]. Jama Journal of the American Medical Association,2014,312(23):2531−2541. doi: 10.1001/jama.2014.16658
[60]	HUSSAIN T A, MATHEW T C, DASHTI A A, et al. Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes[J]. Nutrition,2012,28(10):1016−1021. doi: 10.1016/j.nut.2012.01.016
[61]	MENG Y, BAI H, WANG S, et al. Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: A systematic review and meta-analysis of randomized controlled trials[J]. Diabetes Research and Clinical Practice,2017,131:124−131. doi: 10.1016/j.diabres.2017.07.006
[62]	YANCY WS, FOY M, CHALECKI AM, et al. A low-carbohydrate, ketogenic diet to treat type 2 diabetes[J]. Nutrition & Metabolism,2005,2(1):34.
[63]	ORMAZABAL V, NAIR S, ELFEKY O, et al. Association between insulin resistance and the development of cardiovascular disease[J]. Cardiovascular Diabetology,2018,17(1):122. doi: 10.1186/s12933-018-0762-4
[64]	LORI E A, KASUEN M, DEEPIKA G. Patients with prediabetes or type 2 diabetes mellitus in a medically supervised diet program[J]. The Journal for Nurse Practitioners,2020,16(8):612−616. doi: 10.1016/j.nurpra.2020.05.001
[65]	KANIKARLA-MARIE P, JAIN S K. Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes[J]. Free Radical Biology and Medicine,2016,95:268−277. doi: 10.1016/j.freeradbiomed.2016.03.020
[66]	GERSHUNI V M, YAN S L, MEDICI V. Nutritional Ketosis for weight management and reversal of metabolic syndrome[J]. Current Nutrition Reports,2018,7(3):97−106. doi: 10.1007/s13668-018-0235-0
[67]	赵岩, 李力, 董贤慧, 等. 生酮饮食干预2型糖尿病疗效的Meta分析[J]. 实用临床医药杂志,2020,24(18):87−97. [ZHAO Y, LI L, DONG X H, et al. Effect of ketogenic diet in the treatment of patients with type 2 diabetes: A meta-analysis[J]. Journal of Clinical Medicine in Parctice,2020,24(18):87−97. ZHAO Y, LI L, DONG X H, et al. Effect of ketogenic diet in the treatment of patients with type 2 diabetes: a Meta-analysis[J]. Journal of Clinical Medicine in Parctice, 2020, 24(18): 87-97.
[68]	RAWSHANI A, RAWSHANI A, GUDBJORNSDOTTIR S. Mortality and cardiovascular disease in type 1 and type 2 diabetes[J]. The New England Journal of Medicine,2017,377(3):300−301. doi: 10.1056/NEJMc1706292
[69]	SECKOLD R, FISHER E, DE BOCK M, et al. The ups and downs of low-carbohydrate diets in the management of type 1 diabetes: A review of clinical outcomes[J]. Diabetic Medicine,2019,36(3):326−334. doi: 10.1111/dme.13845
[70]	CANADA D. Diabetes Canada Position statement on low-carbohydrate diets for adults with diabetes: A rapid review[J]. Canadian Journal of Diabetes, 2020, 44(4) : 295-299.
[71]	SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2019[J]. CA:A Cancer Journal for Clinicians,2019,69(1):7−34. doi: 10.3322/caac.21551
[72]	庞广昌, 陈庆森, 胡志和. 乳酸盐代谢及其在健康中的关键作用[J]. 食品科学, 2012, 33(1): 1-15. PANG G C, CHEN Q S, HU Z H. Metabolism of lactate and its critical role in health[J]. Food Science, 2012, 33(1) : 1-15.
[73]	RIGO P, PAULUS P, KASCHTEN B J, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose[J]. European Journal of Nuclear Medicine,1996,23(12):1641−1674. doi: 10.1007/BF01249629
[74]	GOGVADZE V, ZHIVOTOVSKY B, ORRENIUS S. The Warburg effect and mitochondrial stability in cancer cells[J]. Molecular Aspects of Medicine,2010,31(1):60−74. doi: 10.1016/j.mam.2009.12.004
[75]	OTTO C, KLINGELHOFFER C, BIGGEMANN L, et al. Experimentelle untersuchungen zur verstoffwechselung von ketonkörpern und laktat durch tumorzellen des gastrointestinaltrakts[J]. Aktuel Ernahrungsmed,2014,39(1):51−59. doi: 10.1055/s-0033-1360007
[76]	TISDALE M J, BRENNAN R A, FEARON K C, et al. Reduction of weight loss and tumour size in a cachexia model by a high fat diet[J]. British Journal of Cancer,1987,56(1):39−43. doi: 10.1038/bjc.1987.149
[77]	ALLEN B G, BHATIA S K, BUATTI J M, et al. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts[J]. Clinical cancer research: An Official Journal of the American Association for Cancer Research,2013,19(14):3905−3913. doi: 10.1158/1078-0432.CCR-12-0287
[78]	ABDELWAHAB M G, FENTON K E, PREUL M C, et al. The Ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma[J]. Plos One,2012,7(5):e36197. doi: 10.1371/journal.pone.0036197
[79]	ZAHRA A, FATH MA, OPAT E, et al. Consuming a ketogenic diet while receiving radiation and chemotherapy for locally advanced lung cancer and pancreatic cancer: The university of iowa experience of two phase 1 clinical trials[J]. Radiation Research,2017,187(6):743−754. doi: 10.1667/RR14668.1
[80]	ARRUEBO M, VILABOA N, SAEZ-GUTIERREZ B, et al. Assessment of the evolution of cancer treatment therapies[J]. Cancers,2011,3(3):3279−3330. doi: 10.3390/cancers3033279
[81]	ZUCCOLI G, MARCELLO N, PISANELLO A, et al. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case report[J]. Nutrition & Metabolism,2010,7(1):33.
[82]	SCHMIDT M, PFETZER N, SCHWAB M, et al. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial[J]. Nutrition & Metabolism,2011,8(1):54.
[83]	IYIKESICI M S, SLOCUM A K, SLOCUM A, et al. Efficacy of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy for stage IV triple-negative breast cancer[J]. Cureus,2017,9(7):e1445.
[84]	FURUKAWA K, SHIGEMATUS K, IWASE Y, et al. Clinical effects of one year of chemotherapy with a modified medium-chain triglyceride ketogenic diet on the recurrence of stage IV colon cancer[J]. Journal of Clinical Oncology,2018,36(15):e15709.
[85]	KLEMENT R J, SCHAFER G, SWEENEY R A. A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: An interim analysis of the KETOCOMP study[J]. Journal of Traditional and Complementary Medicine,2019,10(3):180−187.
[86]	SHAFER P. About epilepsy: The basics. The epilepsy foundation website[EB/OL]. http://www.epilepsy.com/learn/about-epilepsy-basics. Published September 2014. Accessed October 1, 2015.
[87]	KWAN P, ARZIMANOGLOU A, BERG A, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies[J]. Epilepsia,2010,51(6):1069−1077.
[88]	SHARMA S, SANKHYAN N, GULATI S, et al. Use of the modified a tkins diet for treatment of refractory childhood epilepsy: A randomized controlled trial[J]. Epilepsia,2013,54(3):481−486. doi: 10.1111/epi.12069
[89]	CARABALLO R H, CERSÓSIMO R O, SAKR D, et al. Ketogenic diet in patients with dravet syndrome[J]. Epilepsia,2005,46(9):1539−1544. doi: 10.1111/j.1528-1167.2005.05705.x
[90]	GROOMES L B. Do patients with absence epilepsy respond to ketogenic diets?[J]. Journal of Child Neurology,2011,26(2):160−165. doi: 10.1177/0883073810376443
[91]	HENDERSON C B. Efficacy of the ketogenic diet as a treatment option for epilepsy: Meta-analysis[J]. Journal of Child Neurology,2006,21(3):193−198. doi: 10.2310/7010.2006.00044
[92]	COPPOLA G, VERROTTI A, AMMENDOLA E, et al. Ketogenic diet for the treatment of catastrophic epileptic encephalopathies in childhood[J]. European Journal of Paediatric Neurology,2010,14(3):229−234. doi: 10.1016/j.ejpn.2009.06.006
[93]	KIM J A, YOON J R, LEE E J, et al. Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy[J]. Epilepsia,2016,57(1):51−58. doi: 10.1111/epi.13256
[94]	VAN DER LOUW E, VAN DEN HURK D, NEAL E, et al. Ketogenic diet guidelines for infants with refractory epilepsy[J]. European Journal of Paediatric Neurology,2016,20(6):798−809. doi: 10.1016/j.ejpn.2016.07.009
[95]	RIANTARINI I, KIM H D, KO A, et al. Short- and long-term seizure-free outcomes of dietary treatment in infants according to etiology[J]. Seizure,2019,71:100−104. doi: 10.1016/j.seizure.2019.06.002
[96]	JANA R-H, ELVIRA C-V, ISABEL P-S, et al. Efficacy and safety of ketogenic dietary theraphies in infancy. A single-center experience in 42 infants less than two years of age[J]. Seizure: European Journal of Epilepsy,2021,92:106−111. doi: 10.1016/j.seizure.2021.08.018
[97]	PULSIFER M B, GORDON J M, BRANDT J, et al. Effects of ketogenic diet on development and behavior: Preliminary report of a prospective study[J]. Developmental Medicine & Child Neurology,2001,43(5):301−306.
[98]	PATEL A, PYZIK P L, TURNER Z, et al. Long-term outcomes of children treated with the ketogenic diet in the past[J]. Epilepsia,2010,51(7):1277−1282. doi: 10.1111/j.1528-1167.2009.02488.x
[99]	VINING E P. Long-term health consequences of epilepsy diet treatments[J]. Epilepsia,2008,49:27−29. doi: 10.1111/j.1528-1167.2008.01828.x
[100]	RAVASCO P, MONTEIRO-GRILLO I, VIDAL P M, et al. Nutritional deterioration in cancer: The role of disease and diet[J]. Clinical Oncology,2003,15(8):443−450. doi: 10.1016/S0936-6555(03)00155-9
[101]	ARRIETA O, ORTEGA R M M, VILLANUEVA-RODRÍGUEZ G, et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: A prospective study[J]. BMC Cancer,2010,10(1):50. doi: 10.1186/1471-2407-10-50
[102]	LAVIANO A, SEELAENDER M, SANCHEZ-LARA K, et al. Beyond anorexia-cachexia. Nutrition and modulation of cancer patients' metabolism: Supplementary, complementary or alternative anti-neoplastic therapy?[J]. European Journal of Pharmacology,2011,668:S87−S90. doi: 10.1016/j.ejphar.2011.06.060
[103]	LIN Tie, YANG Jing, HONG Xuan, et al. Nutritional status in patients with advanced lung cancer undergoing chemotherapy: A prospective observational study[J]. Nutrition and Cancer,2020,72(7):1225−1230. doi: 10.1080/01635581.2019.1675720
[104]	CAAN B J, MEYERHARDT J A, KROENKE C H, et al. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study)[J]. Cancer Epidemiology Biomarkers & Prevention,2017,26(7):1008−1015.
[105]	CASTELLANA M, CONTE E, CIGNARELLI A, et al. Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis[J]. Reviews in Endocrine and Metabolic Disorders,2020,21(3):5−16.
[106]	WANG D, PASCUAL J M, YANG H, et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects[J]. Annals of Neurology,2005,57(1):111−118. doi: 10.1002/ana.20331
[107]	WEXLER I D, HEMALATHA S G, MCCONNELl J, et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets: Studies in patients with identical mutations[J]. Neurology,1997,49(6):1655−1661. doi: 10.1212/WNL.49.6.1655
[108]	KOSSOFF E H, ZUPEC-KANIA B A, AMARK P E, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the international ketogenic diet study group[J]. Epilepsia,2009,50(2):304−317. doi: 10.1111/j.1528-1167.2008.01765.x

Supplements (0)

Cited By

Cited by

Periodical cited type(2)

1.	谭婉静，张笑薇，白泓，李晓凤，余以刚，肖性龙. 丁香油与月桂酸对金黄色葡萄球菌的协同抑制作用. 现代食品科技. 2022(02): 278-285+265 .
2.	于航，王海默，钟世勋，吕月琴，刘兆胜，孙汝江. 抗菌肽APSH-07与抗生素对常见致病菌的体外协同抗菌效果研究. 饲料工业. 2021(16): 22-26 .